Somatic stem cells and their dysfunction in endometriosis
-
Women’s Health
Women’s Health
Women’s health, a vital aspect of medical science, encompasses various conditions unique to women’s physiological makeup. Historically, women were often excluded from clinical research, leading to a gap in understanding the intricacies of women’s health needs. However, recent advancements have highlighted the significant role that the microbiome plays in these conditions, offering new insights and potential therapies. MicrobiomeSignatures.com is at the forefront of exploring the microbiome signature of each of these conditions to unravel the etiology of these diseases and develop targeted microbiome therapies.
Microbiome Signatures identifies and validates condition-specific microbiome shifts and interventions to accelerate clinical translation. Our multidisciplinary team supports clinicians, researchers, and innovators in turning microbiome science into actionable medicine.
Karen Pendergrass
What was studied?
The study focused on the role of somatic stem cells (SSCs), including endometrial stem cells (EnSCs) and bone marrow-derived mesenchymal stem cells (MSCs), in the pathogenesis of endometriosis. This was conducted through a comprehensive literature review, including in vitro experiments and studies on animal models and human tissue analyses. The research examined the contributions of these stem cells to the development and growth of endometriosis, exploring their genetic, phenotypic, and functional characteristics as well as their involvement in the disease’s mechanisms.
Who was studied?
The study subjects included stem cells derived from human and animal endometrium and stem cells involved in endometriosis pathology sourced from menstrual blood and bone marrow. This research compiled evidence from various sources, including previously conducted experiments and clinical observations focusing on how these stem cells contribute to the formation and progression of endometriosis lesions in women affected by the disease and in relevant animal models.
What were the most important findings?
Clonality and Origin of Lesions: Evidence suggests that ovarian endometriotic cysts and peritoneal endometriotic lesions may arise from a clonal origin, indicating a possible stem cell basis for the disease.
Stem Cell Dysregulation: Stem cells, particularly EnSCs and MSCs, exhibit dysregulated behaviors in endometriosis, such as increased proliferation, invasiveness, and altered expression of markers that suggest a stem cell-like undifferentiated state.
Contribution to Lesion Growth: Bone marrow-derived stem cells, including MSCs and endothelial progenitor cells, were found to contribute to the pathogenesis and growth of endometriotic lesions by promoting angiogenesis and possibly by transdifferentiating into endometrial-like cells.
Molecular and Phenotypic Alterations: Stem/progenitor cells in endometriotic lesions display a range of genetic and epigenetic alterations and an increased expression of pro-angiogenic factors, which are crucial for lesion survival and growth.
What are the greatest implications of this study?
Diagnostic Advancements: The findings suggest that markers identified in the stem cells associated with endometriosis could potentially be used to develop non-invasive diagnostic tests with higher sensitivity and specificity, aiding in early disease detection.
Therapeutic Interventions: Targeting dysfunctional stem cells or their altered pathways offers a promising strategy for developing more effective treatments. This could include interventions that inhibit the recruitment and proliferation of these cells at ectopic sites or modify their angiogenic and inflammatory behaviors.
Understanding Disease Mechanisms: By integrating stem cell-based insights into the pathogenesis of endometriosis, this study supports a more comprehensive understanding of the disease’s etiology, which can lead to more targeted and effective clinical management strategies.
The emphasis on stem cell contributions to endometriosis not only opens up new avenues for research but also highlights potential therapeutic targets that could significantly improve the management and treatment of endometriosis, potentially improving the quality of life for affected women.